Depression, historical aspects

Author/s
Rashid Zaman
Citation
Issue 5 Winter 2018
CEPiP.2018.1.1-4
Abstract

Depression, a relatively modern term, first introduced in 19th century replacing melancholy, was first described as far back as 2000 BCE in ancient Mesopotamia. The understanding of the causes and treat¬ment of depression has evolved over the centuries with Europeans in the Middle Ages regarding it as a condition caused by the spirits that needed exorcisms by priests and in worst cases the death of the suf¬ferer. Whilst more humane understanding and treatments were practiced in the rising Islamic civilisation during the Middle Ages, it was not until the 20th century that knowledge gained from medical science began to be applied to its understanding and treatment, with the latter remaining somewhat limited until the 1960s with the introduction of tricyclic antidepressants. Depression is a complex disorder with biological, psychological and social factors contributing to its development; it is therefore not surprising that multiple methods incorporating biological and psychosocial methods are likely to be needed for an effective treatment. The complexity of depression has not yet allowed full understanding of its causes and pathophysiology, and hence not resulted in totally effective treatment. In this brief article, I will chart the history of depression, its proposed causes and treatment, from the ancient times to the modern era.

Cite as: Cutting Edge Psychiatry in Practice 2018, 5(1):1-4 https://doi.org/10.65031/cdyi3536

References

  1. Berrios GE. The history of mental symptoms: descriptive psychopathology since the nineteenth century. Cambridge University Press; 1996 Apr 11. https://doi.org/10.1017/cbo9780511526725
  2. Haque A. Psychology from Islamic perspective: Contributions of early Muslim scholars and challenges to contemporary Muslim psychologists. Journal of Religion and Health. 2004 Dec 1;43(4):357-77. https://doi.org/10.1007/s10943-004-4302-z
  3. Angst J, Marneros A. Bipolarity from ancient to modern times: conception, birth and rebirth. Journal of Affective Disorders. 2001 Dec 1;67(1-3):3-19. https://doi.org/10.1016/s0165-0327(01)00429-3
  4. Schneider K. The layering of the emotional life and the structure of states of depression. Zeitschrift fur die Gesamte Neurologie und Psychiatrie. 1920 Jan 1;59:281-6.  
  5. Cade JF, Malhi GS. Cade’s lithium. Acta Neuropsychiatrica. 2007 Apr;19(2):125-6. https://doi.org/10.1111/j.1601-5215.2007.00196.x
  6. Lapin IP, Oxenkrug GF. Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect. The Lancet. 1969 Jan 18;293(7586):132-6. https://doi.org/10.1016/s0140-6736(69)91140-4
  7. Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, Krystal JH. Antidepressant effects of ketamine in depressed patients. Biological Psychiatry. 2000 Feb 15;47(4):351-4. https://doi.org/10.1016/s0006-3223(99)00230-9
  8. Zarate CA, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, Charney DS, Manji HK. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Archives of General Psychiatry. 2006 Aug 1;63(8):856-64. https://doi.org/10.1001/archpsyc.63.8.856
  9. Sanacora G, Schatzberg AF. Ketamine: promising path or false prophecy in the development of novel therapeutics for mood disorders? Neuropsychopharmacology. 2015 Jan;40(2):259. https://doi.org/10.1038/npp.2014.261
  10. Akhtar H, Bukhari F, Nazir M, Anwar MN, Shahzad A. Therapeutic efficacy of neurostimulation for depression: techniques, current modalities, and future challenges. Neuroscience Bulletin. 2016 Feb 1;32(1):115-26. https://doi.org/10.1007/s12264-015-0009-2
  11. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nature Reviews Neuroscience. 2008 Jan;9(1):46. https://doi.org/10.1038/nrn2297